Isoflurane inhaled at the onset of reperfusion potentiates the cardioprotective effect of ischemic postconditioning through a NO-dependent mechanism

Journal of Cardiovascular Pharmacology

Volumn 47, Issue 3, 2006, Pages 487-492

  Tessier Vetzel, Dominique ^a,b   Tissier, Renaud ^a,b   Waintraub, Xavier ^a,b   Ghaleh, Bijan ^a,b,c   Berdeaux, Alain ^a,b,c,d  

^a UNIVERSITÉ PARIS EST CRÉTEIL   (France)

^b ECOLE NATIONALE VÉTÉRINAIRE D ALFORT   (France)

^c HENRI MONDOR HOSPITAL   (France)

^d FACULTÉ DE MÉDECINE   (France)

Author keywords

isoflurane; Myocardial infarction; Nitric oxide; Postconditioning

Indexed keywords

ARGININE; ISOFLURANE; N(G) NITROARGININE METHYL ESTER; PENTOBARBITAL; INHALATION ANESTHETIC AGENT; NITRIC OXIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORONARY REPERFUSION; DRUG EFFECT; EXPERIMENT; HEART INFARCTION; HEART INFARCTION PREVENTION; HEART INFARCTION SIZE; HEART MUSCLE REPERFUSION; HEART PROTECTION; INHALATION ANESTHESIA; ISCHEMIC PRECONDITIONING; MALE; NONHUMAN; PRIORITY JOURNAL; RABBIT; STATISTICAL SIGNIFICANCE; ANIMAL; BLOOD PRESSURE; HEART RATE; INHALATIONAL DRUG ADMINISTRATION; PATHOLOGY; PHYSIOLOGY; REPERFUSION INJURY;

ADMINISTRATION, INHALATION; ANESTHETICS, INHALATION; ANIMALS; BLOOD PRESSURE; HEART RATE; ISCHEMIC PRECONDITIONING, MYOCARDIAL; ISOFLURANE; MALE; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION INJURY; NITRIC OXIDE; RABBITS;

EID: 33745713616     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.fjc.0000211731.69045.fe     Document Type: Article

References (21)

1. Zhao ZQ, Corvera JS, Halkos ME, et al. Inhibition of myocardial injury by ischemic postconditioning during reperfusion: comparison with ischemic preconditioning. Am J Physiol. 2003;285:H579-H588.
2. Halkos ME, Kerendi F, Corvera JS, et al. Myocardial protection with postconditioning is not enhanced by ischemic preconditioning. Ann Thorac Surg. 2004;78:961-969.
3. Kin H, Zhao ZQ, Sun HY, et al. Postconditioning attenuates myocardial ischemia-reperfusion injury by inhibiting events in the early minutes of reperfusion. Cardiovasc Res. 2004;62:74-85.
4. Tsang A, Hausenloy DJ, Mocanu MM, et al. Postconditioning: a form of "modified reperfusion" protects the myocardium by activating the phosphatidylinositol 3-kinase-Akt pathway. Circ Res. 2004;95:230-232.
5. Argaud L, Gateau-Roesch O, Raisky O, et al. Postconditioning inhibits mitochondrial permeability transition. Circulation. 2005;111:194-197.
6. Yang XM, Proctor JB, Cui L, et al. Multiple, brief coronary occlusions during early reperfusion protect rabbit hearts by targeting cell signaling pathways. J Am Coll Cardiol. 2004;44:1103-1110.
7. Yang XM, Philipp S, Downey JM, et al. Postconditioning's protection is not dependent on circulating blood factors or cells but involves adenosine receptors and requires PI3-kinase and guanylyl cyclase activation. Basic Res Cardiol. 2005;100:57-63.
8. Schwartz LM, Lagranha CJ. Ischemic postconditioning during reperfusion activates Akt and ERK without protecting against lethal myocardial ischemia-reperfusion injury in pigs. Am J Physiol. 2005;290:H1011-H1018. Oct 7:Epub ahead of print.
9. Staat P, Rioufol G, Piot C, et al. Postconditioning the human heart. Circulation. 2005;112:2143-2148.
10. 2+ overload. Am J Physiol. 2005;288:H1900-H1908.
11. Serviddio G, Di Venosa N, Federici A, et al. Brief hypoxia before normoxic reperfusion (postconditioning) protects the heart against ischemia-reperfusion injury by preventing mitochondria peroxyde production and glutathione depletion. FASEB J. 2005;19:354-361.
12. Chiari PC, Bienengraeber MW, Pagel PS, et al. Isoflurane protects against myocardial infarction during early reperfusion by activation of phosphatidylinositol-3-kinase signal transduction: evidence for anesthetic-induced postconditioning in rabbits. Anesthesiology. 2005;102:102-109.
13. Feng J, Lucchinetti E, Ahuja P, et al. Isoflurane postconditioning prevents opening of the mitochondrial permeability transition pore through inhibition of glycogen synthase kinase 3beta. Anesthesiology. 2005;103:987-995.
14. Krolikowski JG, Bienengraeber M, Weihrauch D, et al. Inhibition of mitochondrial permeability transition enhances isoflurane-induced cardioprotection during early reperfusion: the role of mitochondrial KATP channels. Anesth Analg. 2005;101:1590-1596.
15. Tissier R, Aouam K, Berdeaux A, et al. Evidence for a ceiling of cardioprotection with a nitric oxide donor-induced delayed preconditioning in rabbits. J Pharmacol Exp Ther. 2003;306:528-531.
16. Cope DK, Impastato WK, Cohen MV, et al. Volatile anesthetics protect the ischemic rabbit myocardium from infarction. Anesthesiology. 1997;86:699-709.
17. Schlack W, Preckel B, Stunneck D, et al. Effects of halothane, enflurane, isoflurane, sevoflurane and des.urane on myocardial reperfusion injury in the isolated rat heart. Br J Anaesth. 1998;81:913-919.
18. Krolikowski JG, Weihrauch D, Bienengraeber M, et al. Role of Erk1/2, p70s6 K, and eNOS in isoflurane-induced cardioprotection during early reperfusion in vivo. Can J Anaesth. 2006;53:174-182.
19. Krieg T, Qin Q, Philipp S, et al. Acetylcholine and bradykinin trigger preconditioning in the heart through a pathway that includes Akt and NOS. Am J Physiol. 2004;287:H2606-H2611.
20. Balakirev MYu, Khramtsov VV, Zimmer G. Modulation of the mitochondrial permeability transition by nitric oxide. Eur J Biochem. 1997;246:710-718.
21. Costa AD, Garlid KD, West IC, et al. Protein kinase G transmits the cardioprotective signal from cytosol to mitochondria. Circ Res. 2005;97:329-336.